干细胞景观的综合性表征确定了用于鼻癌治疗的新型干细胞相关基因
Dahua Xu1,2, Bocen Chen3, Yutong Shen1,2
1School of Intelligent Medicine and Technology, Big Data Research Center, Hainan General Hospital and Hainan Affiliated Hospital, Hainan Medical University, Haikou 571199, China.
Cancers
|February 13, 2026
概括
这项研究确定了两种鼻癌 (NPC) 亚型,揭示了不同的茎状特征和免疫微环境特征. 新型茎度标志物为积极的NPC提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 癌症干细胞生物学
- 免疫基因组学是什么
背景情况:
- 转移和复发是鼻癌 (NPC) 治疗的关键挑战.
- 癌症干细胞 (CSC) 与NPC进展和治疗耐药性有关.
- 对于NPC患者的CSC异质性和干性标志物仍然不太了解.
研究的目的:
- 在NPC患者中识别不同的干部亚型.
- 调查与这些亚型相关的临床结果,瘤免疫微环境 (TIME) 和药物反应.
- 发现NPC的新型茎状性相关标记物.
主要方法:
- 基于干细胞基因组活动的共识聚类.
- 权重基因相关性网络分析 (WGCNA) 和Cox回归用于标记物识别.
- 在体外验证,包括球体形成试验和西式涂抹.
主要成果:
- 确定了两种NPC亚型 (C1和C2),C2表现出较高的茎度,更差的预后和侵袭性瘤进展.
- 观察到瘤干度和TIME透之间的反向相关性.
- 确定PSMC3IP,NABP2,CDC45和HJURP是促进CSC特性和影响治疗反应的相关基因.
结论:
- 两种不同的NPC亚型具有不同的干度,临床和TIME特征的特征.
- 已识别的茎状标记物为克服NPC转移和复发提供了潜在的治疗点.
相关概念视频
Induced Pluripotent Stem Cells
28.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Adult Stem Cells
33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Stem Cell Therapy for Tissue Regeneration
4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Embryonic Stem Cells
32.7K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.7K
Embryonic Stem Cells
5.2K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.2K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K


